The companies to be acquired, InvaGen Pharmaceuticals Inc and Exelan Pharmaceuticals Inc, had combined sales of $225 million in the last twelve months to June 2015, Cipla said in a statement.

Earlier, Cipla's UK subsidiary Cipla (EU) acquired Brazilian firm Duomed Produtos Farmaceuticos for about Rs 2.6 crore.

The deal was the approval of Brazilian health authority (ANVISA) and other regulatory authorities to import and distribute pharmaceutical products in Brazil.

Latest News  from Business News Desk